Match tier Listed
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-10-06

Galen R. Wenger

High Impact

Role not yet determined Is this you? Add your title

UAMS primary NCTR

Also affiliated: West Virginia University (1970–1973); Society for Neuroscience (2001); National Institute on Drug Abuse (2003); Harvard University (1977–1980); West Virginia University Hospitals (1970); University of Chicago (1989); National Institute on Alcohol Abuse and Alcoholism (2003); University of Wisconsin–Milwaukee (1999); University of Colorado Anschutz (1976); University of Colorado Denver (1976)

28 h-index 212 pubs 2,239 cited

Research Areas

Biomedical Subjects

  • Animals
  • Male
  • Reinforcement Schedule
  • Dose-Response Relationship, Drug
  • Columbidae
  • Conditioning, Operant
  • Mice
  • Pentobarbital
  • Phencyclidine
  • Dextroamphetamine
  • Behavior, Animal
  • Rats
  • Motor Activity
  • Humans
  • Morphine

Links

Research Group

OverviewAI-generated summary

Galen R. Wenger's research group focuses on behavioral pharmacology, investigating the effects of various substances on animal behavior. His work has explored the dose-response relationships of drugs such as amphetamine, phencyclidine, ketamine, and pentobarbital in mice, examining how these substances alter schedule-controlled behavior. Wenger has also studied the underlying neurochemical mechanisms related to drug effects, including the role of biogenic amines in drug-induced alterations of seizure thresholds.

With an h-index of 29 and over 2,320 citations across 221 publications, Wenger is recognized as a highly cited researcher. His research has been active recently, with publications spanning from the 1970s to more recent work. His group's investigations contribute to understanding the complex interactions between drugs, neurochemistry, and behavior, with implications for the study of substance abuse and neurological disorders.

Metrics

  • h-index: 28
  • Publications: 212
  • Citations: 2,239

Selected Publications

  • Rate-Dependency Theory (2015)
    DOI OpenAlex
  • Low Bone Turnover and Low BMD in Down Syndrome: Effect of Intermittent PTH Treatment (2012)
    PLoS ONE 57 citations DOI OpenAlex
  • Working memory in the aged Ts65Dn mouse, a model for Down syndrome (2012)
    Behavioural Brain Research 11 citations DOI OpenAlex
  • Low bone turnover and low bone density in a cohort of adults with Down syndrome (2012)
    Osteoporosis International 83 citations DOI OpenAlex
  • Rate-Dependency Theory (2010)
    DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

90 Collaborators 18 Institutions 3 Countries

Top Collaborators

Similar Researchers

Based on overlapping research topics

Brenda M. Gannon University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies Behavioral and Psychological Studies Neuroscience and Neuropharmacology Research
Strong match 5 shared topics
Michael D. Berquist University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies Behavioral and Psychological Studies Neuroscience and Neuropharmacology Research
Strong match 5 shared topics
Luísa Camacho National Center for Toxicological Research
Pharmacological Effects and Toxicity Studies Behavioral and Psychological Studies Disease Models, Animal
Good match 5 shared topics
Jai Shankar K. Yadlapalli University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies Neuroscience and Neuropharmacology Research Animal Behavior and Welfare Studies
Good match 4 shared topics
Andrew F. Perin University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies Behavioral and Psychological Studies Neuroscience and Neuropharmacology Research
Good match 4 shared topics
Navdeep Dogra University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies Neuroscience and Neuropharmacology Research Disease Models, Animal
Good match 5 shared topics